Click Here For No Down Payment Medical Practice Financing for medical doctor practice start-ups and practice acquisitions!
Call: 904-551-6090
It is our deep understanding that you have very unique needs that are diverse from the rest the clients who want to have their own medical practice centers. We have set up systems in our company that will ensure that you get custom services that will meet your needs. Through this you will be able to attain the proper financial package. The attaining of the set company goals will hence be easy with the excellent medical practice loans start up company system.
Read The Interesting Snippets Below For Exciting Health-Care News!
Khosla-backed startup hopes to bring doctors to patients' mobiles
– http://www.reuters.com/healthNews
SAN FRANCISCO (Reuters) – HealthTap Chief Executive Officer Ron Gutman believes paying the doctor a visit is expensive and time-consuming. So why not bring the doctor to the patient – digitally?
* TSX down 126.27 points, or 0.81 percent, at 15,398.55 * Eight of 10 main index sectors decline * Valeant tumbles 7.4 percent after cutting outlook By John Tilak TORONTO, July 31 (Reuters) – Canada’s main stock index declined on Thursday as Argentina’s default kindled worries about the stability of the economic recovery in the region and shares of Valeant Pharmaceuticals International fell after the company cut its outlook…
FREETOWN (Reuters) – Sierra Leone declared a state of emergency and called in troops to quarantine Ebola victims on Thursday, joining neighboring Liberia in imposing tough controls as the death toll from the worst-ever outbreak of the virus hit 729 in West Africa.
July 31 (Reuters) – Canada’s Valeant Pharmaceuticals International Inc, embroiled in a bitter battle to take over Botox-maker Allergan Inc, on Thursday cut its 2014 and 2015 profit forecasts, sending shares 10 percent lower.
UPDATE 1-Teva Pharm raises full-year profit forecast after solid second quarter
– http://www.reuters.com
* Now sees 2014 EPS $4.50-$4.80 with Copaxone competition
PARIS, July 31 (Reuters) – Sanofi expects to submit regulatory applications for the world’s first dengue vaccine in the first quarter of 2015 and the French drugmaker could start selling the first batches at the end of that year, CEO Chris Viehbacher said on Thursday.
Practice Financing For Doctors!
No down payment medical, dental and healthcare provider practice financing here! + More News: Sierra Leone declares emergency as Ebola death toll hits 729 + MORE 07/31/2014
No comments:
Post a Comment